↓ Skip to main content

Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features

Overview of attention for article published in Clinical Drug Investigation, July 2019
Altmetric Badge

Mentioned by

twitter
1 tweeter
Title
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Published in
Clinical Drug Investigation, July 2019
DOI 10.1007/s40261-019-00826-0
Authors

Katherine A. Lyseng-Williamson

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2019.
All research outputs
#11,870,787
of 13,385,708 outputs
Outputs from Clinical Drug Investigation
#553
of 609 outputs
Outputs of similar age
#144,139
of 177,869 outputs
Outputs of similar age from Clinical Drug Investigation
#2
of 3 outputs
Altmetric has tracked 13,385,708 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 609 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,869 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.